Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04292171 · ClinicalTrials.gov registry record · Early Phase 1
Gabapentin for Perioperative Pain Relief in Surgical Abortion
A Early Phase 1 study, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 219
- Enrollment target
NCT04292171: Completed Early Phase 1 study, sponsored by University of Nevada, Las Vegas.
NCT04292171 is a Early Phase 1 study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 219 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (313% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04292171, a Early Phase 1 study, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 219 participants
- Enrollment target
Study Summary
Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.
Primary Outcome
100mm Visual analog scale (VAS) for level of pain, 1-100, 1=no pain, 100= extreme pain
Interventions
- DRUG Placebos
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-03-30 |
| Phase | Early Phase 1 |
What the finished NCT04292171 record still lists
NCT04292171 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (313% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04292171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04292171 about?
NCT04292171 is a clinical study titled "Gabapentin for Perioperative Pain Relief in Surgical Abortion". Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.
What is the current status of trial NCT04292171?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 219 participants. The study started on 2017-05-01. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT04292171?
The interventions under investigation include: Placebos (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT04292171?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04292171's enrollment target sits among peer trials
219 56th of 2000 higher than 1,945 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI